Skip to main content

Placebo’s Double Whammy

Sham treatments can both reduce pain and increase pleasure, and do so affecting similar circuitry in the brain.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, ROBIN_24Expectations give placebos their power, allowing them to dramatically alter our experience of a stimulus. Researchers demonstrate in Proceedings of the National Academy of Sciences today (October 14) that not only can placebos tamp down feelings of pain, they can also ramp up pleasurable sensations. It all depends on where a person starts. If she is expecting an improvement in pain, her sensory processing decreases. If, on the other hand, she anticipates a heightened sense of pleasure, then the sensory processing is magnified.

The researchers, led by Dan-Mikael Ellingsen at Gothenburg University in Sweden, offered a nasal spray placebo (supposedly containing oxytocin) or nothing at all to 30 study participants. On one day, the participants received gentle strokes on the left arm; on another day, a painful heat stimulus. In the pain scenario, the nasal spray was tied to a decrease in pain sensation, and in the pleasure scenario, it was associated with an increase in pleasure, compared to the times when the person was given no spray.

Using functional MRI, the researchers found increases in activity in the posterior insula and primary and secondary somatosensory areas—regions involved in sensory processing—during the pleasurable arm stroke placebo treatments. They also found decreases in these areas during the painful heat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays